WE‐E‐BRB‐08

Commissioning and Benchmarking a 3D Dosimetry System for Clinical Use

A. Thomas, Joseph R Newton, J. Adamovics, M. Oldham

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To commission and benchmark a 3D dosimetry system for clinical use, in particular, for verification and commissioning of complex radiation treatments like VMAT, IMRT and gated treatments. The system is composed of two parts: a radiochromic plastic dosimeter Presage, which responds to absorbed dose with a linear change in optical‐density; and the Duke Large field of view Optical‐CT Scanner (DLOS). Methods: DLOS commissioning involved creating stray light and spectral corrections, determining the dynamic range, spatial resolution, and noise, and characteristics of source and imaging components. The benchmarking tests were performed on the combined DLOS/Presage system to establish baseline capabilities. These tests consisted of delivering 6 treatments of gradually increasing complexity, and comparing the measured distributions with a gold standard (e.g. machine beam‐data). All studies used standard‐ procedures to ensure consistency. Results: Commissioning: isotropic spatial resolution was sub‐mm (MTF >0.5 for frequencies of 1.5;p/mm) and the dynamic range was ∼ 60dB. Flood field uniformity was 10% and stable after 45minutes. Stray light is small, due to telecentricity, but even the residual can be removed through deconvolution. Benchmarking: the mean 3D passing gamma rate (3%, 3mm, 5% dose threshold) over the 6 benchmark data sets was 97.3% ± 0.6% (range 96%–98%), indicating excellent ability to perform 3D dosimetry. Noise was low at ∼2% for 2mm reconstructions. Conclusions: The DLOS/Presage benchmark tests show consistently excellent performance, with very good agreement to simple known distributions. The telecentric design was critical to enabling fast (∼15mins) imaging with minimal stray light artifacts. The system produces accurate isotropic 2mm3 dose data over clinical volumes (e.g. 16cm diameter phantoms, 12 cm height), and represents a uniquely useful and versatile new tool for commissioning complex therapy techniques. The system also has wide versatility, and has successfully been used in preliminary tests with protons, and kV irradiations.

Original languageEnglish (US)
Pages (from-to)3817
Number of pages1
JournalMedical Physics
Volume38
Issue number6
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Benchmarking
Light
Noise
Bleeding Time
Artifacts
Plastics
Protons
Radiation

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

WE‐E‐BRB‐08 : Commissioning and Benchmarking a 3D Dosimetry System for Clinical Use. / Thomas, A.; Newton, Joseph R; Adamovics, J.; Oldham, M.

In: Medical Physics, Vol. 38, No. 6, 2011, p. 3817.

Research output: Contribution to journalArticle

Thomas, A. ; Newton, Joseph R ; Adamovics, J. ; Oldham, M. / WE‐E‐BRB‐08 : Commissioning and Benchmarking a 3D Dosimetry System for Clinical Use. In: Medical Physics. 2011 ; Vol. 38, No. 6. pp. 3817.
@article{e3e48bc8fb2b4c20ae084fbad7e2928b,
title = "WE‐E‐BRB‐08: Commissioning and Benchmarking a 3D Dosimetry System for Clinical Use",
abstract = "Purpose: To commission and benchmark a 3D dosimetry system for clinical use, in particular, for verification and commissioning of complex radiation treatments like VMAT, IMRT and gated treatments. The system is composed of two parts: a radiochromic plastic dosimeter Presage, which responds to absorbed dose with a linear change in optical‐density; and the Duke Large field of view Optical‐CT Scanner (DLOS). Methods: DLOS commissioning involved creating stray light and spectral corrections, determining the dynamic range, spatial resolution, and noise, and characteristics of source and imaging components. The benchmarking tests were performed on the combined DLOS/Presage system to establish baseline capabilities. These tests consisted of delivering 6 treatments of gradually increasing complexity, and comparing the measured distributions with a gold standard (e.g. machine beam‐data). All studies used standard‐ procedures to ensure consistency. Results: Commissioning: isotropic spatial resolution was sub‐mm (MTF >0.5 for frequencies of 1.5;p/mm) and the dynamic range was ∼ 60dB. Flood field uniformity was 10{\%} and stable after 45minutes. Stray light is small, due to telecentricity, but even the residual can be removed through deconvolution. Benchmarking: the mean 3D passing gamma rate (3{\%}, 3mm, 5{\%} dose threshold) over the 6 benchmark data sets was 97.3{\%} ± 0.6{\%} (range 96{\%}–98{\%}), indicating excellent ability to perform 3D dosimetry. Noise was low at ∼2{\%} for 2mm reconstructions. Conclusions: The DLOS/Presage benchmark tests show consistently excellent performance, with very good agreement to simple known distributions. The telecentric design was critical to enabling fast (∼15mins) imaging with minimal stray light artifacts. The system produces accurate isotropic 2mm3 dose data over clinical volumes (e.g. 16cm diameter phantoms, 12 cm height), and represents a uniquely useful and versatile new tool for commissioning complex therapy techniques. The system also has wide versatility, and has successfully been used in preliminary tests with protons, and kV irradiations.",
author = "A. Thomas and Newton, {Joseph R} and J. Adamovics and M. Oldham",
year = "2011",
doi = "10.1118/1.3613375",
language = "English (US)",
volume = "38",
pages = "3817",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - WE‐E‐BRB‐08

T2 - Commissioning and Benchmarking a 3D Dosimetry System for Clinical Use

AU - Thomas, A.

AU - Newton, Joseph R

AU - Adamovics, J.

AU - Oldham, M.

PY - 2011

Y1 - 2011

N2 - Purpose: To commission and benchmark a 3D dosimetry system for clinical use, in particular, for verification and commissioning of complex radiation treatments like VMAT, IMRT and gated treatments. The system is composed of two parts: a radiochromic plastic dosimeter Presage, which responds to absorbed dose with a linear change in optical‐density; and the Duke Large field of view Optical‐CT Scanner (DLOS). Methods: DLOS commissioning involved creating stray light and spectral corrections, determining the dynamic range, spatial resolution, and noise, and characteristics of source and imaging components. The benchmarking tests were performed on the combined DLOS/Presage system to establish baseline capabilities. These tests consisted of delivering 6 treatments of gradually increasing complexity, and comparing the measured distributions with a gold standard (e.g. machine beam‐data). All studies used standard‐ procedures to ensure consistency. Results: Commissioning: isotropic spatial resolution was sub‐mm (MTF >0.5 for frequencies of 1.5;p/mm) and the dynamic range was ∼ 60dB. Flood field uniformity was 10% and stable after 45minutes. Stray light is small, due to telecentricity, but even the residual can be removed through deconvolution. Benchmarking: the mean 3D passing gamma rate (3%, 3mm, 5% dose threshold) over the 6 benchmark data sets was 97.3% ± 0.6% (range 96%–98%), indicating excellent ability to perform 3D dosimetry. Noise was low at ∼2% for 2mm reconstructions. Conclusions: The DLOS/Presage benchmark tests show consistently excellent performance, with very good agreement to simple known distributions. The telecentric design was critical to enabling fast (∼15mins) imaging with minimal stray light artifacts. The system produces accurate isotropic 2mm3 dose data over clinical volumes (e.g. 16cm diameter phantoms, 12 cm height), and represents a uniquely useful and versatile new tool for commissioning complex therapy techniques. The system also has wide versatility, and has successfully been used in preliminary tests with protons, and kV irradiations.

AB - Purpose: To commission and benchmark a 3D dosimetry system for clinical use, in particular, for verification and commissioning of complex radiation treatments like VMAT, IMRT and gated treatments. The system is composed of two parts: a radiochromic plastic dosimeter Presage, which responds to absorbed dose with a linear change in optical‐density; and the Duke Large field of view Optical‐CT Scanner (DLOS). Methods: DLOS commissioning involved creating stray light and spectral corrections, determining the dynamic range, spatial resolution, and noise, and characteristics of source and imaging components. The benchmarking tests were performed on the combined DLOS/Presage system to establish baseline capabilities. These tests consisted of delivering 6 treatments of gradually increasing complexity, and comparing the measured distributions with a gold standard (e.g. machine beam‐data). All studies used standard‐ procedures to ensure consistency. Results: Commissioning: isotropic spatial resolution was sub‐mm (MTF >0.5 for frequencies of 1.5;p/mm) and the dynamic range was ∼ 60dB. Flood field uniformity was 10% and stable after 45minutes. Stray light is small, due to telecentricity, but even the residual can be removed through deconvolution. Benchmarking: the mean 3D passing gamma rate (3%, 3mm, 5% dose threshold) over the 6 benchmark data sets was 97.3% ± 0.6% (range 96%–98%), indicating excellent ability to perform 3D dosimetry. Noise was low at ∼2% for 2mm reconstructions. Conclusions: The DLOS/Presage benchmark tests show consistently excellent performance, with very good agreement to simple known distributions. The telecentric design was critical to enabling fast (∼15mins) imaging with minimal stray light artifacts. The system produces accurate isotropic 2mm3 dose data over clinical volumes (e.g. 16cm diameter phantoms, 12 cm height), and represents a uniquely useful and versatile new tool for commissioning complex therapy techniques. The system also has wide versatility, and has successfully been used in preliminary tests with protons, and kV irradiations.

UR - http://www.scopus.com/inward/record.url?scp=85024803732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024803732&partnerID=8YFLogxK

U2 - 10.1118/1.3613375

DO - 10.1118/1.3613375

M3 - Article

VL - 38

SP - 3817

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -